Vendor status logFDA letter
Summit Research Peptides: status log
Domain redirects to parked page; FDA letter Dec 10 2024
Domains: summitpeptides.shop · Last checked 2026-10-19 · Reviewed by Amino Wire Editorial Team
Summary
FDA sent Summit Research Peptides (Hoover, Alabama) a warning letter dated December 10, 2024 covering semaglutide, retatrutide, cagrilintide, tirzepatide and mazdutide products. On October 19, 2026 the domain redirected to a ww38 subdomain typical of parked domains.
Dated facts
1 entries · newest first-
FDA warning letter
FDA warning letter 695607: website reviewed October 2024; five GLP-1-class products found to be unapproved new drugs despite “RESEARCH USE ONLY” labeling.
Source: FDA warning letter: Summit Research Peptides (695607)
Our site checks
automated · single location| Checked (UTC) | URL | HTTP | What loaded |
|---|---|---|---|
| 2026-10-19 06:18:02 | https://summitpeptides.shop/→ https://ww38.summitpeptides.shop/ | 200 | Redirected to ww38.summitpeptides.shop, a pattern commonly used by domain-parking services. No storefront observed. |
A page loading does not show that a business is lawful, that orders are fulfilled, or anything about product quality. We did not place orders.